Prelude Therapeutics Inc - Common Stock, par value $0.0001 per share (PRLD)

61 filings reported holding PRLD - Prelude Therapeutics Inc - Common Stock, par value $0.0001 per share as of Q1 2024.
Prelude Therapeutics Inc - Common Stock, par value $0.0001 per share (PRLD) has 55 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 34.2M shares of 44.2M outstanding shares and own 77.43% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (10.9M shares), BAKER BROS. ADVISORS LP (10.1M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (4.13M shares), Boxer Capital, LLC (2.57M shares), BlackRock Inc. (1.1M shares), VANGUARD GROUP INC (1.02M shares), PRICE T ROWE ASSOCIATES INC /MD/ (942K shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (508K shares), GEODE CAPITAL MANAGEMENT, LLC (362K shares), and Sio Capital Management, LLC (320K shares).
This table shows the top 55 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.